In addition, the system of QRFPR (also known as GPR103) and its peptide ligand RFa26 is involved in the regulation of food intake in the hypothalamus, as well as in glucose metabolism and energy metabolism [38], and it is thought to play a role in the development of obesity [38]. Here, QRFPR is linked to obesity disorder.